Toronto Dominion Bank’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $227K | Hold |
15,295
| – | – | ﹤0.01% | 1557 |
|
|
2025
Q4 | $244K | Hold |
15,295
| – | – | ﹤0.01% | 1448 |
|
|
2025
Q3 | $169K | Hold |
15,295
| – | – | ﹤0.01% | 1419 |
|
|
2025
Q2 | $130K | Hold |
15,295
| – | – | ﹤0.01% | 1347 |
|
|
2025
Q1 | $123K | Hold |
15,295
| – | – | ﹤0.01% | 1292 |
|
|
2024
Q4 | $137K | Hold |
15,295
| – | – | ﹤0.01% | 1314 |
|
|
2024
Q3 | $112K | Hold |
15,295
| – | – | ﹤0.01% | 982 |
|
|
2024
Q2 | $87.3K | Hold |
15,295
| – | – | ﹤0.01% | 1071 |
|
|
2024
Q1 | $76.6K | Hold |
15,295
| – | – | ﹤0.01% | 1060 |
|
|
2023
Q4 | $138K | Hold |
15,295
| – | – | ﹤0.01% | 1159 |
|
|
2023
Q3 | $119K | Hold |
15,295
| – | – | ﹤0.01% | 1160 |
|
|
2023
Q2 | $147K | Hold |
15,295
| – | – | ﹤0.01% | 1155 |
|
|
2023
Q1 | $168K | Buy |
15,295
+48
| +0.3% | +$423 | ﹤0.01% | 1153 |
|
|
2022
Q4 | $66K | Hold |
15,247
| – | – | ﹤0.01% | 1314 |
|
|
2022
Q3 | $115K | Sell |
15,247
-88
| -0.6% | -$762 | ﹤0.01% | 1322 |
|
|
2022
Q2 | $153K | Hold |
15,335
| – | – | ﹤0.01% | 1090 |
|
|
2022
Q1 | $190K | Hold |
15,335
| – | – | ﹤0.01% | 1143 |
|
|
2021
Q4 | $351K | Sell |
15,335
-27,800
| -64% | -$659K | ﹤0.01% | 1230 |
|
|
2021
Q3 | $707K | Buy |
43,135
+27,910
| +183% | +$443K | ﹤0.01% | 949 |
|
|
2021
Q2 | $197K | Buy |
15,225
+1,246
| +9% | +$15.9K | ﹤0.01% | 1062 |
|
|
2021
Q1 | $183K | Buy |
13,979
+5,955
| +74% | +$86.4K | ﹤0.01% | 1093 |
|
|
2020
Q4 | $110K | Sell |
8,024
-1,617
| -17% | -$23.5K | ﹤0.01% | 1079 |
|
|
2020
Q3 | $142K | Sell |
9,641
-5,569
| -37% | -$80.7K | ﹤0.01% | 987 |
|
|
2020
Q2 | $247K | Buy |
15,210
+5,698
| +60% | +$91.2K | ﹤0.01% | 984 |
|
|
2020
Q1 | $138K | Sell |
9,512
-22,997
| -71% | -$406K | ﹤0.01% | 976 |
|
|
2019
Q4 | $658K | Buy |
32,509
+19,285
| +146% | +$178K | ﹤0.01% | 929 |
|
|
2019
Q3 | $71K | Sell |
13,224
-11,486
| -46% | -$69.5K | ﹤0.01% | 1190 |
|
|
2019
Q2 | $81.1K | Buy |
24,710
+14,930
| +153% | +$95.2K | ﹤0.01% | 1155 |
|
|
2019
Q1 | $63K | Buy |
9,780
+3,842
| +65% | +$25.5K | ﹤0.01% | 1283 |
|
|
2018
Q4 | $40K | Buy |
5,938
+638
| +12% | +$3.68K | ﹤0.01% | 1249 |
|
|
2018
Q3 | $35K | Sell |
5,300
-430
| -8% | -$2.41K | ﹤0.01% | 1175 |
|
|
2018
Q2 | $33K | Buy |
+5,730
| New | +$32K | ﹤0.01% | 1240 |
|
|
2017
Q1 | – | Sell |
-4
| Closed | – | – | 1197 |
|
|
2016
Q4 | $0 | Sell |
4
-64
| -94% | -$206 | ﹤0.01% | 1227 |
|
|
2016
Q3 | $0 | Buy |
68
+55
| +423% | +$148 | ﹤0.01% | 1197 |
|
|
2016
Q2 | $0 | Sell |
13
-23
| -64% | -$63 | ﹤0.01% | 1189 |
|
|
2016
Q1 | $0 | Sell |
36
-15
| -29% | -$36 | ﹤0.01% | 1214 |
|
|
2015
Q4 | $0 | Sell |
51
-1
| -2% | -$3 | ﹤0.01% | 1060 |
|
|
2015
Q3 | $0 | Buy |
+52
| New | +$178 | ﹤0.01% | 1044 |
|
Other funds holding AUPH
TCM
NMC
Toronto Dominion Bank's AUPH Position: Q1 2026 in Review
Toronto Dominion Bank held its Aurinia Pharmaceuticals (AUPH) position steady in Q1 2026 at 15,295 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #1557.
Toronto Dominion Bank first reported a position in AUPH in Q3 2015 and has held it in 38 quarters since. The position peaked at $707K in Q3 2021. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.
- Toronto Dominion Bank held 15,295 shares of Aurinia Pharmaceuticals worth $227K as of Q1 2026.
- Toronto Dominion Bank left its Aurinia Pharmaceuticals share count unchanged in Q1 2026.
- Aurinia Pharmaceuticals made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1557 holding.
- Toronto Dominion Bank first reported a position in Aurinia Pharmaceuticals in Q3 2015 and has held it in 38 quarters since.
- Toronto Dominion Bank's Aurinia Pharmaceuticals position peaked at $707K in Q3 2021.
- 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.
Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.